PRINCETON, N.J., June 28, 2011 /PRNewswire/ -- GE Healthcare today announced the availability of DaTscan™ (Ioflupane I 123 Injection), in more than 80 hospitals across the US. DaTscan is the first FDA ...
多巴胺转运体成像(DATSCAN)与帕金森病(PD)患者认知、运动及生活质量(QoL)的横断面研究显示,striatal dopaminergic activity Metrics与认知表现或QoL无显著关联,仅与部分运动指标呈modest correlations。研究强调PD的多因素性,需整合神经影像学与全面临床评估。
DUBLIN--(BUSINESS WIRE)--GE Healthcare today presented the results of a randomised controlled study analyzing the effect of DaTSCAN™ (Ioflupane I 123 Injection) SPECT imaging in a group of adult ...
DaTscan is a radioactive diagnostic agent that works by binding reversibly to the human dopamine transporter (DaT) in the brain. The Food and Drug Administration (FDA) has expanded the approval of ...
患者因反复晕厥和癫痫就诊,排除心脏、神经科及内分泌疾病后,神经学检查发现Parkinson样症状及REM睡眠障碍,结合DaTSCAN异常提示多系统萎缩伴帕金森病(MSA-P),强调多学科协作在复杂病例诊断中的重要性。 该病例描述了一位51岁男性患者因疑似低血糖而入院 ...
GE Healthcare’s DaTscan has been approved by the U.S. Food and Drug Administration (FDA) for use in patients with suspected Dementia with Lewy Bodies (DLB). This new indication is in addition to its ...
Thanks to a new diagnostic imaging technique, physicians now have an objective test to evaluate patients for parkinsonian syndromes, such as Parkinson's disease. Northwestern Memorial Hospital is ...
DaTscan is a radiopharmaceutical imaging agent that works by binding to dopamine transporters (DaT) in the brain. A specific marker for DaT, DaTscan produces images that provide visual evidence based ...
The FDA has approved DaTscan (Ioflupane I 123 Injection, from GE Healthcare) for use with single photon emission computed tomography (SPECT) imaging, for the detection of dopamine transporters (DaT) ...
ST. LOUIS, April 05, 2022 (GLOBE NEWSWIRE) -- Curium announced today that its generic version of DaTscan (Ioflupane I 123 Injection) was approved on March 30, 2022, by the U.S. Food and Drug ...
GE Healthcare today presented the results of a randomized study analyzing the effect of DaTSCAN TM (Ioflupane I 123 Injection) SPECT imaging in a group of adult patients with a diagnosis of possible ...
GE Healthcare today presented the results of a randomised controlled study analyzing the effect of DaTSCAN TM (Ioflupane I 123 Injection) SPECT imaging in a group of adult patients with Clinically ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果